Literature DB >> 7620664

Incidence and prevalence of lymphoedema: a literature review.

V Logan.   

Abstract

Lymphoedema is a significant health problem for some groups of patients and few health authorities have carried out a systematic health needs assessment for this client group. When planning and developing services, there is a need to demonstrate a knowledge of the literature relating to the incidence and prevalence of this condition. To facilitate interpretation of the literature, clarification of the difference between incidence and prevalence rates is included in this review. It is important that the differences between these rates is clearly understood when considering the nature of a chronic, progressive condition. The problems inherent in comparing results from studies which use different definitions of what constitutes 'lymphoedema', as well as different methods of measurement are acknowledged. A number of studies are examined and using information from this review, it is suggested that the prevalence rate of lymphoedema in women treated for breast cancer is in the region of 25-28%. Factors which influence the development of lymphoedema, and the controversy concerning axillary node sampling and dissection are discussed. The need to consider patients with lymphoedema due to very advanced cancer, and those with lower limb problems is also highlighted.

Entities:  

Mesh:

Year:  1995        PMID: 7620664     DOI: 10.1111/j.1365-2702.1995.tb00209.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  11 in total

1.  Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema.

Authors:  Sheila H Ridner
Journal:  Support Care Cancer       Date:  2005-04-06       Impact factor: 3.603

2.  Cluster of symptoms in women with breast cancer treated with curative intent.

Authors:  Alexandre Lopes Evangelista; Erika Maria Monteiro Santos
Journal:  Support Care Cancer       Date:  2011-08-16       Impact factor: 3.603

3.  Low-level laser therapy in management of postmastectomy lymphedema.

Authors:  Ahmad Kaviani; Mohsen Fateh; Reza Yousefi Nooraie; Mohammad-reza Alinagi-zadeh; Leila Ataie-Fashtami
Journal:  Lasers Med Sci       Date:  2006-05-04       Impact factor: 3.161

4.  Knowledge of lymphoedema among primary health care teams: a questionnaire survey.

Authors:  V Logan; S Barclay; W Caan; J McCabe; M Reid
Journal:  Br J Gen Pract       Date:  1996-10       Impact factor: 5.386

5.  Study of incidence of lymphedema in Indian patients undergoing axillary dissection for breast cancer.

Authors:  Pramod R Pillai; Shekhar Sharma; Sheikh Zahoor Ahmed; D K Vijaykumar
Journal:  Indian J Surg Oncol       Date:  2011-03-04

6.  Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report.

Authors:  Kathleen Meeske; Ashley Wilder Smith; Catherine M Alfano; Bonnie A McGregor; Anne McTiernan; Kathy B Baumgartner; Kathleen E Malone; Bryce B Reeve; Rachel Ballard-Barbash; Leslie Bernstein
Journal:  Qual Life Res       Date:  2007-04-25       Impact factor: 4.147

Review 7.  The treatment of lymphedema related to breast cancer: a systematic review and evidence summary.

Authors:  Lyn Kligman; Rebecca K S Wong; Mary Johnston; Nancy S Laetsch
Journal:  Support Care Cancer       Date:  2004-04-17       Impact factor: 3.603

8.  Postoperative education concerning the use of the upper limb, and exercise and treatment of the upper limb: cross-sectional survey of 105 breast cancer patients.

Authors:  Anne Kärki; Riitta Simonen; Esko Mälkiä; James Selfe
Journal:  Support Care Cancer       Date:  2004-04-03       Impact factor: 3.603

9.  Procedural Recommendations for Lymphoscintigraphy in the Diagnosis of Peripheral Lymphedema: the Genoa Protocol.

Authors:  G Villa; C C Campisi; M Ryan; F Boccardo; P Di Summa; M Frascio; G Sambuceti; C Campisi
Journal:  Nucl Med Mol Imaging       Date:  2019-01-07

10.  Causes of shoulder pain in women with breast cancer-related lymphedema: a pilot study.

Authors:  Ho Joong Jeong; Young-Joo Sim; Ki Hun Hwang; Ghi Chan Kim
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.